It is likely that some form of drug reimportation will be approved by the U.S. Congress this year, if not in the next few weeks.

Americans have for many years been paying the world's highest prices for pharmaceuticals--but is it more than their fair share?

There are good reasons to worry about the prospect of adding drug reimportation provisions to health care overhaul legislation.

This paper identifies two mechanisms through which price regulation (or reimportation) may exert an influence on research and development.

Consumers should understand how reimportation would work if it were actually put in place, because it would be a classic example of unintended consequences.

Extensive reimportation would likely have destroyed the incentives that U.S. firms have to develop new drugs.

This collection of essays provides an indication of the range and depth of AEI’s work in health care reform and pharmaceutical policy.

After the war on terror, the war against the drug companies may be the single biggest issue in our country today. If the enemieshave their way, many maladieswill continue to plague us.